We are live on ! Find out more
LKFT

Lakefront Biotherapeutics American Depositary Shares
LKFT

85 hedge funds and large institutions have $887M invested in Lakefront Biotherapeutics American Depositary Shares in 2025 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 25 increasing their positions, 24 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more call options, than puts

Call options by funds: $28.7M | Put options by funds: $16M

17% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 18

13% more capital invested

Capital invested by funds: $783M → $887M (+$104M)

2% more funds holding

Funds holding: 83 → 85 (+2)

4% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 24

0.77% more ownership

Funds ownership: 47.33% → 48.1% (+0.77%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

Holders
85
Holders Change
+2
Holders Change %
+2.41%
% of All Funds
1.12%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
21
Increased
25
Reduced
24
Closed
18
Calls
$28.7M
Puts
$16M
Net Calls
+$12.8M
Net Calls Change
+$15M

Top Buyers

Rank Fund Capital Flow
1
MAP
Madison Avenue Partners
New York
+$50.3M
2
EC
EcoR1 Capital
California
+$23.6M
3
PM
Prosight Management
Texas
+$12.3M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$9.16M
5
Renaissance Technologies
Renaissance Technologies
New York
+$3.59M

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$36.5M
2
DTC
Deep Track Capital
Connecticut
-$18.6M
3
FC
Finepoint Capital
Massachusetts
-$16.5M
4
NM
Newtyn Management
New York
-$5.02M
5
VPC
Vestal Point Capital
New York
-$5.02M
Name Holding Trade Value Shares
Change 		Change in
Stake
Ameriprise
26
Ameriprise
Minnesota
$1.53M -$268K -9,995 -15%
CGH
27
Crossmark Global Holdings
Texas
$1.33M -$50.7K -1,890 -4%
Barclays
28
Barclays
United Kingdom
$1.12M +$223K +8,309 +26%
XT
29
XTX Topco
Cayman Islands
$1.11M +$1.07M +39,803 New
SCM
30
Suvretta Capital Management
New York
$1.04M – – –
MAM
31
Monaco Asset Management
Monaco
$1.01M – – –
AA
32
ALPS Advisors
Colorado
$990K -$346K -12,908 -27%
Verition Fund Management
33
Verition Fund Management
Connecticut
$876K +$33.2K +1,238 +4%
Jane Street
34
Jane Street
New York
$861K -$2.14M -80,008 -72%
Bank of America
35
Bank of America
North Carolina
$848K -$785K -29,300 -49%
American Century Companies
36
American Century Companies
Missouri
$787K +$7.05K +263 +0.9%
JF
37
Jump Financial
Illinois
$692K +$663K +24,730 New
BFM
38
Boothbay Fund Management
New York
$612K +$586K +21,866 New
Two Sigma Investments
39
Two Sigma Investments
New York
$606K -$737K -27,502 -56%
MNBTD
40
Moody National Bank Trust Division
Texas
$584K -$142K -5,291 -20%
EGM
41
Engineers Gate Manager
New York
$560K +$536K +19,990 New
PCM
42
Prelude Capital Management
New York
$540K – – –
BCM
43
Barometer Capital Management
Ontario, Canada
$474K +$91.1K +3,400 +25%
Susquehanna International Group
44
Susquehanna International Group
Pennsylvania
$425K -$207K -7,729 -34%
QCM
45
QRG Capital Management
Illinois
$423K +$145K +5,399 +56%
EAM
46
Erste Asset Management
Austria
$392K – – –
CSS
47
Cubist Systematic Strategies
Connecticut
$346K +$332K +12,371 New
Citadel Advisors
48
Citadel Advisors
Florida
$328K +$314K +11,707 New
ACM
49
Aquatic Capital Management
Illinois
$300K -$357K -13,316 -55%
EWM
50
Empirical Wealth Management
Washington
$261K +$250K +9,312 New
1
2
3 4 5

LKFT Hedge Fund Activity: Q2 2025 in Review

85 of the 7,598 institutional investors tracked by Wall St. Rank reported a position in Lakefront Biotherapeutics American Depositary Shares (LKFT) for Q2 2025, worth a combined $887M — up 13% from $783M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new LKFT positions and 18 closed out — a net gain of 3 holders — while 25 added to existing stakes and 24 trimmed.

The largest buyer was Madison Avenue Partners, opening a new position worth an estimated $50.3M. The largest seller was BVF Inc, exiting entirely with an estimated $36.5M sold.

  • 85 institutional investors held Lakefront Biotherapeutics American Depositary Shares (LKFT) as of Q2 2025, up from 83 in Q1 2025.
  • Funds reported $887M of Lakefront Biotherapeutics American Depositary Shares stock for Q2 2025, up 13% quarter-over-quarter.
  • 21 funds opened new Lakefront Biotherapeutics American Depositary Shares positions in Q2 2025 and 18 closed out, a net change of +3 holders.
  • The largest Lakefront Biotherapeutics American Depositary Shares buyer in Q2 2025 was Madison Avenue Partners, an estimated $50.3M added.
  • The largest Lakefront Biotherapeutics American Depositary Shares seller in Q2 2025 was BVF Inc, an estimated $36.5M sold.

Based on aggregated 13F filings for Q2 2025.